Sign in
A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2018
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema
Raj K. Maturi, MD
Category: AMD-Neovascular